CD4^LVFOXP3

CD4^LVFOXP3 appears to be a code name or experimental designation for a cell therapy or gene therapy product involving CD4+ T cells engineered to express FOXP3, the transcription factor critical for regulatory T cell (Treg) development and function. Regulatory T cells are immunosuppressive and play key roles in maintaining immune tolerance, preventing autoimmunity, and modulating immune responses[1][2][6]. The "LV" in the name likely refers to lentiviral vector-mediated gene transfer. This approach is used experimentally to generate induced regulatory T cells (iTregs) with enhanced suppressive activity for potential therapeutic use in autoimmune diseases, transplantation, or cancer immunotherapy.